« Previous
Next »
Digestive and Liver Disease
Volume 42, Issue 7
, Pages 515-519
, July 2010
Transcatheter arterial chemoembolisation for hepatocellular carcinoma in cirrhosis: Survival rate and prognostic factors
References
- GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide, version 1.0. 1.0 ed.. Lyon: IARC Press; 2001;
- Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153–156
- Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35:421–430
- . Management of hepatocellular carcinoma. Hepatology. 2005;1208–2005
- . Hepatocellular carcinoma. Lancet. 2003;362:1907–1917
- . Chemoembolization for hepatocellular carcinoma. Gastroenterology. 2004;127:S179–S188
- . Hepatocellular carcinoma: interventional bridging to liver transplantation. Transplantation. 2005;80:S113–S119
- . Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–1236
- . Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37:429–442
- Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35:1164–1171
- Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology. 2002;224:47–54
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with 178 unresectable hepatocellular carcinoma: a randomized trial. Lancet. 2002;359:1734–1739
- . Catheter replacement of the needle in percutaneous arteriography; a new technique. Acta Radiol. 1953;39:368–376
- . Non parametric estimation from incomplete observation. J Am Stat Assoc. 1958;53:457–481
- . Multivariate survival analysis using Cox's regression model. Hepatology. 1987;7:1346–1358
- Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology. 2006;131:461–469
- Unresectable hepatocellular carcinoma: survival and prognostic factors after lipiodol chemoembolisation in 89 patients. Digest Liver Dis. 2006;38:125–133
- Prognosis following transcatheter arterial embolization for 121 patients with unresectable hepatocellular carcinoma with or without a history of treatment. World J Gastroenterol. 2006;12:2075–2079
- Local Therapeutic results of computed tomography-guided transcatheter chemoembolization for hepatocellular carcinoma: results of 256 tumors in 79 patients. Cardiovasc Intervent radiol. 2007;30:1144–1155
- Transcatheter chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: a multivariate analysis of prognostic factors. J Clin Gastroenterol. 1999;28:334–340
- A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter chemoembolization. Cancer. 2000;88:50–57
- Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study. Clin Gastroenterol Hepatol. 2005;3:918–925
- Predictors of outcome in patients with unresectable hepatocellular carcinoma receiving transcatheter arterial chemoembolization. Aliment Pharmacol Ther. 2007;26:393–400
- Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization. Scand J Gastroenterol. 2009;44:346–357
- Predictive factors of tumor response to trans-catheter treatment in cirrhotic patients with hepatocellular carcinoma: a multivariate analysis of pre findings. World J Gastroenterol. 2007;13:6022–6026
- Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology. 2004;40:1352–1360
- Radio-frequency thermal ablation (RFTA) of small hepatocellular carcinoma in patients with cirrhosis. Experience at a single tertiary referral center. Minerva Gastroenterol Dietol. 2005;51:171–178
- Unita Interdipartimentale Neoplasie Epatiche (U.I.N.E) Group. Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study. J Hepatol. 2005;42:535–540
- Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, percutaneous acetic acid injection to treat hepatocellular carcinoma of 3
cm or less. Gut. 2005;54:1151–1156[Erratum in: Gut 2005;54(October (10)):1508] - Clinical impact of selective transarterial chemoembolization on hepatocellular carcinoma: a cohort study. World J Gastroenterol. 2009;15:1843–1849
- Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology. 1993;188:79–83
- Segmental transctheter arterial embolization for primary hepatocellular carcinoma. World J Gastroenterol. 1998;4:511–512
PII: S1590-8658(09)00419-8
doi: 10.1016/j.dld.2009.09.012
© 2009 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Inc All rights reserved.
« Previous
Next »
Digestive and Liver Disease
Volume 42, Issue 7
, Pages 515-519
, July 2010
